Archive: 20/09/2013
Prostacyclin analogs and PDE 5 inhibitors synergistically stimulate ATP release from human RBCs
Researchers at Saint Louis University School of Medicine have discovered a novel interaction between prostacyclin (PGI2) analogs and phosphodiesterase 5 (PDE5) inhibitors, two groups of drugs used in the treatment of pulmonary ...
Sep 20, 2013